Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.33 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RRM1 | P23921 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27763046 | 1.00 | ALOX15 (0.36) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL3722670 | 1.00 | ALOX15 (0.36) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| Hydrochloric Acid SCHEMBL9762986 | 0.98 | ALOX15 (0.36) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL3732825 | 0.95 | ALOX15 (0.34) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL1419586 | 0.95 | ALOX15 (0.34) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL1881323 | 0.95 | ALOX15 (0.34) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| Hydrochloric Acid SCHEMBL28067883 | 0.94 | ALOX15 (0.33) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| Hydrochloric Acid SCHEMBL28067882 | 0.94 | ALOX15 (0.33) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| Acetic Acid SCHEMBL28510404 | 0.93 | ALOX15 (0.33) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL8015555 | 0.87 | ALOX15 (0.31) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005761-A | Methods of treating diseases and conditions using interleukin-10 | 阿尔莫生物科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4388013-A1 | STRATEGY FOR HIGHLY SUPERIOR DR5 ACTIVATION INCLUDING IN TUMORS AND CANCERS | University of Virginia Patent Foundation (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4341298-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND REGULATING FIBRONECTIN-INTEGRIN INTERACTIONS AND SIGNALING | University of Virginia Patent Foundation (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-2023196881-A2 | BCL6 INHIBITORY PEPTIDE COMPOSITIONS AND METHODS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2023-10-12 | — | — | WO | disclosed |
| CN-116601304-A | Compositions and methods relating to activatable therapeutic agents | 阿穆尼克斯制药公司 | 2023-08-15 | — | — | CN | disclosed |
| EP-4214239-A1 | COMPOSITIONS AND METHODS FOR OVERCOMING DR5-INDUCED IMMUNE EVASION BY SOLID TUMORS | University of Virginia Patent Foundation (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023137404-A1 | SPIKE FURIN CLEAVAGE IS A SARS-COV-2 TARGETING STRATEGY TO BREAK THE CHAIN OF INFECTION CYCLE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2023-07-20 | — | — | WO | disclosed |
| EP-4185705-A1 | COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS | Amunix Pharmaceuticals, Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| WO-2023081861-A1 | ENHANCED EXPRESSION VIA AUTOTRANSPORTERS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2023-05-11 | — | — | WO | disclosed |
| EP-4171609-A1 | CYTOKINE CONJUGATES | Amunix Pharmaceuticals, Inc. (US) | 2023-05-03 | — | — | EP | disclosed |
| CN-1596119-A | Modification of feeding behavior | IMP COLLEGE INNOVATIONS LTD (GB) | 2005-03-16 | — | — | CN | disclosed |
| EP-1482987-A1 | MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004064595-A2 | MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | BRACCO INTERNATIONAL BV (NL) | 2004-08-05 | — | — | WO | disclosed |
| WO-2003084574-A1 | MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | BRACCO INTERNATIONAL BV (NL) | 2003-10-16 | — | — | WO | disclosed |
| US-5763404-A | LUTEINIZING HORMONE RELEASING HORMONE | UNIV TEXAS (US) | 1998-06-09 | — | — | US | disclosed |
| US-5470947-A | Lutenizing hormone-releasing hormone, contraceptives | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0377665-B1 | EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE | UNIV TEXAS (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0377665-A1 | EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE. | UNIV TEXAS (US) | 1990-07-18 | — | — | EP | disclosed |
| WO-1989001944-A1 | EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-03-09 | — | — | WO | disclosed |
| EP-0196841-A1 | N,N-dialkylguanidino dipeptides | SYNTEX (U.S.A.) INC. (US) | 1986-10-08 | — | — | EP | disclosed |